文献速递肿瘤 PET/CT核素与放射性配体治疗

人工智能去噪算法在68Ga-PSMA-11 PET中的成像质量:在前列腺癌生化复发患者中的验证

Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer.
PubMed 文献 · EJNMMI Res · 2023-05-25

该回顾性研究纳入30例前列腺癌生化复发患者,对68Ga-PSMA-11 PET-CT图像用SubtlePET®去噪算法分别以四分之一、一半、四分之三或全部采集数据重新处理。VPFX衍生序列使用一半数据时分类优于标准重建(p<0.001),Q.Clear序列使用一半信号时分类无差异;SubtlePET®显著降低病灶SUV(p<0.005)并升高肝脏本底(p<0.005),对各阅片者诊断性能无实质影响。

要点

  • VPFX衍生序列用一半数据时分类优于标准重建(p<0.001),Q.Clear序列用一半信号时分类无差异。
  • SubtlePET®显著降低病灶SUV(p<0.005)并升高肝脏本底(p<0.005)。
  • SubtlePET®对各阅片者诊断性能无实质影响,但显著改变定量测量。

核心结论

  • SubtlePET®可用于使用一半信号的68Ga-PSMA扫描,图像质量与Q.Clear序列相似且优于VPFX序列。
  • SubtlePET®显著改变定量测量,若随访中应用标准算法则不应将其用于对比检查。

研究设计与样本

  • 回顾性纳入30例前列腺癌生化复发患者,均接受68Ga-PSMA-11 PET-CT检查。
  • 模拟仅使用四分之一、一半、四分之三或全部采集数据并经SubtlePET®去噪算法重新处理的图像。
  • 由三名不同经验水平的医师盲法分析每个序列,并使用5级Likert量表评估系列。

主要发现

  • VPFX衍生序列使用一半数据时分类不同但优于标准重建(p<0.001)。
  • Q.Clear序列使用一半信号时分类无差异。
  • 部分序列有噪声,但对病灶可检测性无显著影响(p>0.05)。
  • SubtlePET®显著降低病灶SUV(p<0.005)并升高肝脏本底(p<0.005)。
  • SubtlePET®对各阅片者诊断性能无实质影响。

关键数值与推荐

  • 图像质量采用5级Likert量表评估。
  • 病灶可检测性采用二分类标准比较各序列。
  • 诊断性能比较各序列的灵敏度、特异度和准确率。

临床怎么用

  • SubtlePET®可用于使用一半信号的68Ga-PSMA扫描,图像质量与Q.Clear序列相似且优于VPFX序列。
  • 若随访中应用标准算法,则不应将SubtlePET®用于对比检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 68 Ga-PSMA PET is the leading prostate cancer imaging technique, but the image quality remains noisy and could be further improved using an artificial intelligence-based denoising algorithm. To address this issue, we analyzed the overall quality of reprocessed images compared to standard reconstructions. We also analyzed the diagnostic performances of the different sequences and the impact of the algorithm on lesion intensity and background measures. METHODS: We retrospectively included 30 patients with biochemical recurrence of prostate cancer who had undergone 68 Ga-PSMA-11 PET-CT. We simulated images produced using only a quarter, half, three-quarters, or all of the acquired data material reprocessed using the SubtlePET® denoising algorithm. Three physicians with different levels of experience blindly analyzed every sequence and then used a 5-level Likert scale to assess the series. The binary criterion of lesion detectability was compared between series. We also compared lesion SUV, background uptake, and diagnostic performances of the series (sensitivity, specificity, accuracy). RESULTS: VPFX-derived series were classified differently but better than standard reconstructions (p < 0.001) using half the data. Q.Clear series were not classified differently using half the signal. Some series were noisy but had no significant effect on lesion detectability (p > 0.05). The SubtlePET® algorithm significantly decreased lesion SUV (p < 0.005) and increased liver background (p < 0.005) and had no substantial effect on the diagnostic performance of each reader. CONCLUSION: We show that the SubtlePET® can be used for 68 Ga-PSMA scans using half the signal with similar image quality to Q.Clear series and superior quality to VPFX series. However, it significantly modifies quantitative measurements and should not be used for comparative examinations if standard algorithm is applied during follow-up.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Margail C, Merlin C, Billoux T, et al. Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer. EJNMMI Res. 2023. PMID: 37231229. doi:10.1186/s13550-023-00999-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。